Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
2,850,581
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-5,721,431
-
Total reported value, excl. options
-
$0
-
Value change
-
-$346,113
-
Number of sells
-
-12
Significant Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q2 2024
12 filings reported holding SBFM - Sunshine Biopharma Inc. - Common Stock, $0.001 par value as of Q2 2024.
Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 2,850,581 outstanding shares and own 0% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (0 shares), HRT FINANCIAL LP (0 shares), XTX Topco Ltd (0 shares), OSAIC HOLDINGS, INC. (0 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (0 shares), TWO SIGMA INVESTMENTS, LP (0 shares), Federation des caisses Desjardins du Quebec (0 shares), BANK OF AMERICA CORP /DE/ (0 shares), JANE STREET GROUP, LLC (0 shares), and CITADEL ADVISORS LLC (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.